Data as of Apr 17
| +0.88 / +7.02%|
The 7 analysts offering 12-month price forecasts for Insmed Inc have a median target of 30.00, with a high estimate of 45.00 and a low estimate of 7.00. The median estimate represents a +123.71% increase from the last price of 13.41.
The current consensus among 7 polled investment analysts is to Buy stock in Insmed Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.